Acrongenomics Inc.

Acrongenomics Inc. is a publicly trading company under the symbol AGNM. The mission of the Company is developing the "BioLED Technology Platform", through a joint development agreement with Molecular Vision Ltd. A unique platform technology integrating microfluidics, polymer light emitting diodes "pLED's" and optical photodetectors. It is intended that this platform becomes a de-facto standard for unlimited applications in the Point-of-Care (PoC) portable Diagnostics field. As an integrated PoC diagnostic testing device the users will be in the Decentralised testing segments of the market where immediate test results can affect the treatment or therapy and change current patient pathways. The driving force for acceptance will be the improved patient treatment and the saving of significant healthcare costs.

Website

14 Rue Kleberg
Geneva CH-1201 Switzerland
+41 22 716 5300